المساهمون: Hwa Kyung Byun, Jee Suk Chang, Sang Hee Im, Youlia M Kirova, Alexandre Arsene-Henry, Seo Hee Choi, Young Up Cho, Hyung Seok Park, Jee Ye Kim, Chang-Ok Suh, Ki Chang Keum, Joo Hyuk Sohn, Gun Min Kim, Ik Jae Lee, Jun Won Kim, Yong Bae Kim, Keum, Ki Chang

مصطلحات موضوعية: Adult, Anthracyclines / therapeutic use, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Body Mass Index, Breast Neoplasms / complications, Breast Neoplasms / therapy, Bridged-Ring Compounds / adverse effects, Bridged-Ring Compounds / therapeutic use, Clinical Decision-Making, Combined Modality Therapy / adverse effects, Female, Humans, Lymph Node Excision / adverse effects, Lymphedema / etiology, Mastectomy / adverse effects, Middle Aged, Nomograms, Radiotherapy / adverse effects, Retrospective Studies, Risk Factors, Taxoids / adverse effects, Taxoids / therapeutic use, Trastuzumab / adverse effects, Trastuzumab / therapeutic use

العلاقة: ANNALS OF SURGERY; J00178; OAK-2021-07398; https://ir.ymlib.yonsei.ac.kr/handle/22282913/186810Test; 1528-1140 (; https://journals.lww.com/annalsofsurgery/Fulltext/2021/07000/Risk_of_Lymphedema_Following_Contemporary.29.aspxTest; T202104686; ANNALS OF SURGERY, Vol.274(1) : 170-178, 2021-07

الإتاحة: https://doi.org/10.1097/SLA.0000000000003491Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/186810Test
https://journals.lww.com/annalsofsurgery/Fulltext/2021/07000/Risk_of_Lymphedema_Following_Contemporary.29.aspxTest

المؤلفون: Hershman, Dawn L, Unger, Joseph M, Crew, Katherine D, Minasian, Lori M, Awad, Danielle, Moinpour, Carol M, Hansen, Lisa, Lew, Danika L, Greenlee, Heather, Fehrenbacher, Louis, Wade, James L, 3rd, Wong, Siu-Fun, Hortobagyi, Gabriel N, Meyskens, Frank L, Albain, Kathy S

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20)

مصطلحات موضوعية: Acetylcarnitine: administration & dosage, adverse effects, Adult, Aged, Breast Neoplasms: drug therapy, pathology, surgery, Chemotherapy, Adjuvant, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Linear Models, Mastectomy: methods, Middle Aged, Multivariate Analysis, Nerve Regeneration: drug effects, Peripheral Nervous System Diseases: chemically induced, prevention & control, Reference Values, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Taxoids: adverse effects, therapeutic use, Treatment Outcome, acetylcarnitine, taxoid, adjuvant chemotherapy, adult, aged, article, breast tumor, chemically induced disorder, comparative study, controlled clinical trial, controlled study, diet supplementation, dose response, double blind procedure, drug administration, drug effect, female, follow up, human, mastectomy, methodology, middle aged, multivariate analysis, nerve regeneration, pathology, peripheral neuropathy, randomized controlled trial, reference value, risk assessment, sensitivity and specificity, severity of illness index, statistical model, treatment outcome, Acetylcarnitine, Adult, Aged, Breast Neoplasms, Chemotherapy, Adjuvant, Dietary Supplements, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Linear Models, Mastectomy, Middle Aged, Multivariate Analysis, Nerve Regeneration, Peripheral Nervous System Diseases, Reference Values, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Taxoids, Treatment Outcome

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/4ph1164gTest

المؤلفون: Joana Lima, Marta Sousa, Pedro Andrade

المصدر: Revista da Sociedade Portuguesa de Dermatologia e Venereologia, Vol 75, Iss 4 (2018)

مصطلحات موضوعية: Antineoplastic Agents/adverse effects, Drug Eruptions, Psoriasis/chemically induced, Taxoids/adverse effects, Dermatology, RL1-803, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://revista.spdv.com.pt/index.php/spdv/article/view/798Test; https://doaj.org/toc/2182-2395Test; https://doaj.org/toc/2182-2409Test

الوصول الحر: https://doaj.org/article/cb389620ff3e4df5a166077c373d534dTest

المؤلفون: Lima, Joana, Sousa, Marta, Andrade, Pedro

المصدر: Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 75 n. 4 (2017): Outubro - Dezembro; 425-428 ; Journal of the Portuguese Society of Dermatology and Venereology; Vol 75 No 4 (2017): Outubro - Dezembro; 425-428 ; 2182-2409 ; 2182-2395

مصطلحات موضوعية: Antineoplastic Agents/adverse effects, Drug Eruptions, Psoriasis/chemically induced, Taxoids/adverse effects, Antineoplásicos/efeitos adversos, Erupções por Medicamentos, Psoríase/induzida quimicamente, Taxoides/ efeitos adversos

وصف الملف: application/pdf; image/jpeg

العلاقة: https://revista.spdv.com.pt/index.php/spdv/article/view/798/536Test; https://revista.spdv.com.pt/index.php/spdv/article/view/798/733Test; https://revista.spdv.com.pt/index.php/spdv/article/view/798/734Test; https://revista.spdv.com.pt/index.php/spdv/article/view/798Test

الإتاحة: https://doi.org/10.29021/spdv.75.4.798Test
https://revista.spdv.com.pt/index.php/spdv/article/view/798Test

المساهمون: College of Medicine, Dept. of Internal Medicine, Gun Min Kim, Sanghwa Kim, Hyung Seok Park, Jee Ye Kim, Sanggen Nam, Seho Park, Seung Il Kim, DoYoung Kim, Joohyuk Sohn, Kim, Gun Min, Kim, Do Young, Kim, Seung Il, Park, Se Ho, Park, Hyung Seok, Sohn, Joo Hyuk

مصطلحات موضوعية: Alopecia/chemically induced, Alopecia/epidemiology, Alopecia/pathology, Breast Neoplasms/complications, Breast Neoplasms/drug therapy, Breast Neoplasms/epidemiology, Breast Neoplasms/pathology, Bridged-Ring Compounds/administration & dosage, Bridged-Ring Compounds/adverse effects, Chemotherapy, Adjuvant/adverse effects, Cross-Sectional Studies, Cyclophosphamide/administration & dosage, Cyclophosphamide/adverse effects, Doxorubicin/administration & dosage, Doxorubicin/adverse effects, Drug-Related Side Effects and Adverse Reactions/pathology, Female, Humans, Neoplasm Staging, Taxoids/administration & dosage, Taxoids/adverse effects, Adverse reactions, Alopecia, Antineoplastic agents, Breast neopla�뒗, Drug-related side effects

العلاقة: BREAST CANCER RESEARCH AND TREATMENT; J00403; OAK-2017-02764; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160210Test; https://link.springer.com/article/10.1007%2Fs10549-017-4204-xTest; T201701447; BREAST CANCER RESEARCH AND TREATMENT, Vol.163(3) : 527-533, 2017

الإتاحة: https://doi.org/10.1007/s10549-017-4204-xTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160210Test

المؤلفون: Popat, Sanjay, Mellemgaard, Anders, Reck, Martin, Hastedt, Claudia, Griebsch, Ingolf

المصدر: Popat , S , Mellemgaard , A , Reck , M , Hastedt , C & Griebsch , I 2017 , ' Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology : a network meta-analysis vs new therapeutic options ' , Future Oncology , vol. 13 , no. 13 , pp. 1159-1171 . https://doi.org/10.2217/fon-2016-0493Test

مصطلحات موضوعية: Adenocarcinoma/drug therapy, Antibodies, Monoclonal/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, B7-H1 Antigen/genetics, Carcinoma, Non-Small-Cell Lung/drug therapy, Disease-Free Survival, Gene Expression Regulation, Neoplastic/drug effects, Humans, Indoles/adverse effects, Network Meta-Analysis, Taxoids/adverse effects, Treatment Outcome

الإتاحة: https://doi.org/10.2217/fon-2016-0493Test
https://curis.ku.dk/portal/da/publications/nintedanib-plus-docetaxel-as-secondline-therapy-in-patients-with-nonsmallcell-lung-cancer-of-adenocarcinoma-histologyTest(ea1924ad-e2f0-442a-8dcb-0f63ff665bdb).html
http://hdl.handle.net/10044/1/49508Test

المؤلفون: James, N.D., Sydes, M.R., Clarke, N.W., Mason, M.D., Dearnaley, D.P., Spears, M.R., Ritchie, A.W., Parker, C.C., Russell, J.M., Attard, G., de Bono, J., Cross, W., Jones, R.J., Thalmann, G., Amos, C., Matheson, D., Millman, R., Alzouebi, M., Beesley, S., Birtle, A.J., Brock, S., Cathomas, R., Chakraborti, P., Chowdhury, S., Cook, A., Elliott, T., Gale, J., Gibbs, S., Graham, J.D., Hetherington, J., Hughes, R., Laing, R., McKinna, F., McLaren, D.B., O'Sullivan, J.M., Parikh, O., Peedell, C., Protheroe, A., Robinson, A.J., Srihari, N., Srinivasan, R., Staffurth, J., Sundar, S., Tolan, S., Tsang, D., Wagstaff, J., Parmar, M.K.

المساهمون: STAMPEDE investigators, Adab, F., Adeyoju, A., Ahmed, I., Alcock, C., Al-hasso, A., Alonzi, R., Alzouebi, M., Andrade, G., Andrews, S., Ansari, J., Anyamene, N., Azzabi, A., Bahl, A., Ballesteros-Quintail, D., Banerjee, G., Barber, J., Baria, K., Beaney, R., Beesley, S., Beresford, M., Bertelli, G., Bhalla, N., Bhana, R., Birtle, A., Bloomfield, D., Bowen, J., Brady, J., Brierly, R., Brock, S., Brown Richard, B., Brown, S., Button, M., Camilleri, P., Capaldi, L., Castell, F., Chadwick, E., Chakraborti, P., Chan, A., Chan, O., Charnley, N., Chetiyawardana, S., Choudhurey, A., Choudhury, A., Chowdhury, S., Churn, M., Clarke, A., Clarke, N., David, J.C., Cook, A., Cowan, R., Crabb, S., Crawford, M., Crellin, P., Cross, W., Das, T., Davies, J., Dearnaley, D., Dickson, J., Durrani, S., Edwards, A., Eichholz, A., Elliott, T., Eswar, C., Falconer, A., Ferguson, C., Ford, D., Ford, V., Frew, J., Frim, O., Gale, J., Gibbs, S., Glen, H., Graham, J.D., Grant, W., Gray, E., Guerrero-Urbano, T., Gupta, N., Hamid, A., Hamilton, J., Hardman, J., Harland, S., Harper, P., Heath, C., Henry, A., Herbert, C., Hetherington, J., Hill, E., Hilman, S., Hingorani, M., Hofmann, U., Hoskin, P., Huddart, R., Hughes, R., Hughes, S., Ibrahim, A., Jain, S., James, N.

المصدر: Lancet (London, England), vol. 387, no. 10024, pp. 1163-1177

مصطلحات موضوعية: Adult, Aged, 80 and over, Androgen Antagonists/administration & dosage, Androgen Antagonists/adverse effects, Antineoplastic Agents, Hormonal/administration & dosage, Hormonal/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Diphosphonates/administration & dosage, Diphosphonates/adverse effects, Disease Progression, Drug Administration Schedule, Humans, Imidazoles/administration & dosage, Imidazoles/adverse effects, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Prostatic Neoplasms/drug therapy, Taxoids/administration & dosage, Taxoids/adverse effects, Treatment Outcome

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26719232; info:eu-repo/semantics/altIdentifier/eissn/1474-547X; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_2BB6C537D0552; https://serval.unil.ch/notice/serval:BIB_2BB6C537D055Test; urn:issn:0140-6736; https://serval.unil.ch/resource/serval:BIB_2BB6C537D055.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_2BB6C537D0552Test

الإتاحة: https://doi.org/10.1016/S0140-6736Test(15)01037-5
https://serval.unil.ch/notice/serval:BIB_2BB6C537D055Test
https://serval.unil.ch/resource/serval:BIB_2BB6C537D055.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_2BB6C537D0552Test

المؤلفون: Pivot, X., Marmé, F., Koenigsberg, R., Guo, M., Berrak, E., Wolfer, A.

المصدر: Annals of oncology, vol. 27, no. 8, pp. 1525-1531

مصطلحات موضوعية: Adjuvants, Pharmaceutic, Anthracyclines/adverse effects, Anthracyclines/therapeutic use, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Bridged-Ring Compounds/administration & dosage, Bridged-Ring Compounds/adverse effects, Clinical Trials, Phase III as Topic, Disease-Free Survival, Female, Furans/adverse effects, Furans/therapeutic use, Humans, Ketones/adverse effects, Ketones/therapeutic use, Neoplasm Metastasis, Randomized Controlled Trials as Topic, Receptor, ErbB-2/antagonists & inhibitors, ErbB-2/genetics, Taxoids/administration & dosage, Taxoids/adverse effects, Triple Negative Breast Neoplasms/drug therapy, Triple Negative Breast Neoplasms/genetics, Triple Negative Breast Neoplasms/pathology, clinical trial, eribulin, metastatic breast cancer

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27177860; info:eu-repo/semantics/altIdentifier/eissn/1569-8041; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_43D394D01C9D7; https://serval.unil.ch/notice/serval:BIB_43D394D01C9DTest; urn:issn:0923-7534; https://serval.unil.ch/resource/serval:BIB_43D394D01C9D.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_43D394D01C9D7Test

الإتاحة: https://doi.org/10.1093/annonc/mdw203Test
https://serval.unil.ch/notice/serval:BIB_43D394D01C9DTest
https://serval.unil.ch/resource/serval:BIB_43D394D01C9D.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_43D394D01C9D7Test

المساهمون: College of Medicine, Dept. of Internal Medicine, Tracey L. Evans, Byoung Chul Cho, Katalin Udud, Juergen R. Fischer, Frances A. Shepherd, Pablo Martinez, Rodryg Ramlau, Konstantinos N. Syrigos, Liji Shen, Mustapha Chadjaa, Martin Wolf, Cho, Byoung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Humans, Lung Neoplasms/drug therapy, Male, Middle Aged, Platinum Compounds/therapeutic use, Response Evaluation Criteria in Solid Tumors, Retreatment, Small Cell Lung Carcinoma/drug therapy, Survival Rate, Taxoids/adverse effects, Taxoids/therapeutic use, Topotecan/adverse effects, Topotecan/therapeutic use, Cabazitaxel, Phase 2, Small-cell lung cancer, Relapse, Topotecan

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2015-06464; https://ir.ymlib.yonsei.ac.kr/handle/22282913/156987Test; T201505004; JOURNAL OF THORACIC ONCOLOGY, Vol.10(8) : 1221-1228, 2015

الإتاحة: https://doi.org/10.1097/JTO.0000000000000588Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/156987Test

المساهمون: Choong-kun Lee, Minkyu Jung, Sang Joon Shin, Sun Young Rha, Su Jin Heo, Hyun Cheol Chung, Joong Bae Ahn, Mi Ryung Roh, Hyo Song Kim, Hye Ryun Kim, Hye Jin Choi, Roh, Mi Ryung, Kim, Hye Ryun, Kim, Hyo Song, Rha, Sun Young, Shin, Sang Joon, Ahn, Joong Bae, Lee, Choong Kun, Jung, Min Kyu, Chung, Hyun Cheol, Choi, Hye Jin, Heo, Su Jin

المصدر: T201510010.pdf

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Carboplatin/administration & dosage, Carboplatin/adverse effects, Carboplatin/therapeutic use, Dacarbazine/administration & dosage, Dacarbazine/adverse effects, Dacarbazine/therapeutic use, Female, Humans, Male, Melanoma/drug therapy, Middle Aged, Patient Compliance, Taxoids/administration & dosage, Taxoids/adverse effects, Taxoids/therapeutic use, Young Adult, Carboplatin, Docetaxel, Melanoma, Second-line chemotherapy

وصف الملف: 781~789

العلاقة: CANCER RESEARCH AND TREATMENT; J00453; OAK-2015-03806; https://ir.ymlib.yonsei.ac.kr/handle/22282913/141804Test; T201504996; CANCER RESEARCH AND TREATMENT, Vol.47(4) : 781-789, 2015

الإتاحة: https://doi.org/10.4143/crt.2014.261Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141804Test